Oversæt:
EN
Oversæt:
Hyamedix is a Hyaluronan technology platform company specialized in the development and use of various forms of Hyaluronan for research, diagnostics, medical device and therapeutic (drug delivery/release) applications. In addition, we offer extensive product development expertise from formulation through product registration (CE mark).
Hyamedix personnel represent over 30 years experience in Hyaluronan and Hyaluronan related technologies and can help bring your product to market utilising our substantial expertise in:
Our technology portfolio offers unique IP benefits to your products, supplying additional differentiation for your product in your market.
The Hyamedix IP forms the basis of th technologies that utilise the natural benefits of hyaluronan (HA) for devices, diagnostics and drugs:
Hyalink™ X - Hyaluronan based hydrogel crosslinking technology
Hyalink™ X Drygel - Hyaluronan based hydrogel crosslinked drygel
Hyalink™ 3D - 3D printed Hyaluronan hydrogel scaffold/matrix technology.
Our patented Hyaluronan (HA) cross linking technology (Hydrogels & Drygels) hyaluronic acid Hyaluronan cross-linking technology hyaluronic acid formulation
Hyamedix can help in all your
Hyaluronan based formulations, product development, analytical support, production set up and regulatory demands with 30 years experience in developing Hyaluronan based products for the medical device and pharmacutical industries.
Our Patent Pending 3D printed hyaluronan hydrogel scaffolds/matrices for cell culture, regenerative medicine, tissue engineering and drug delivery/release applications
Hyalink™ X is a patented technology for preparing cross-linked Hyaluronan hydrogels. The process results in safe and efficacious products with characteristics specified by the client. The Hyalink™X hydrogels are appropriate for all types of clinical, pre-clinical and research/diagnostic applications. Hydrogel properties are specified by the client after consulting with our formulation scientists.
Hyalink™ X is versatile and adaptable to customers’ specific requirements to produce ready to use devices for many applications and sustained release/depots for drug formulations.
Benefits of Hyalink™ X
Application Areas
Streamlined business model for faster time to market
Access to the Hyalink™ X technology (tech transfer + final hydrogel formulation support) is by license or as bulk (non-sterile or sterile) raw material. In either case, Hyamedix can support you in your product development with our extensive knowledge of Hyluronan in order to enable fast product development.
Our R&D capabilities include, but are not limited to, the investigation of hydrogel swelling, rheology, biodegradation, subsequent processing to suit given applications, compatibility with excipients, active pharmaceutical ingredients (APIs), and preservatives. With an established expertise in Hyaluronan and cross linked Hyaluronan, Hyamedix is here to support in the development of your innovative solutions.
Hyalink™ X Drygel is a patented technology for preparing cross-linked Hyaluronan hydrogels in a dry form. Hyalink™X Drygel can be of varying crosslinking degrees and thicknesses with an average porosity of around 0.4 mm.
Hyalink™ X Drygel can be uploaded with a wide range of drugs for delivery and release applications.
Benefits of Hyalink™ X Drygel
Hyalink™ X Drygel Application Areas
With dedicated formulation labs, Hyamedix can develop proprietary custom formulations based on hyaluronan for many application areas including cosmetics, medical devices and pharmaceuticals.
We have extensive experience working with medical device and pharmaceutical clients developing viscous formulations in the areas of dermo-cosmetics (topical and injectable), dermal fillers, mesotherapy, wound care, ophthalmology, orthopaedics and oncology.
We can also support in the area of drug delivery and controlled release.
Hyamedix can support and help with existing client formulations by optimising those formulations for better processability, sterilisation and/or efficacy in the determined application area.
We can support in the following areas:
With years of experience in Hyaluronan product development, our team can support in getting from the very initial stages of product concept through to product launch.
We have extensive experience working with medical device and pharmaceutical clients developing new products and/or the optimisation of existing products in the areas of dermo cosmetics (topical and injectable), dermal fillers, mesotherapy, wound care, ophthalmology, orthopaedics and oncological applications.
We can also support in the area of drug delivery and controlled release.
With our dedicated analytical labs we can support in a multitude of analyses. Our labs contain, but are not limited to, the following analytical equipment:
With an ever changing regulatory environment, we can help in developing a regulatory plan to meet the needs of any Hyaluronan based medical device or drug product.
We can support in the following areas:
Hyamedix can also assist in any other aspect of developing new products in regards to production and lab set up, scale up and any other production related demands.
Main Features of Hyalink™ 3D
Advantages over other 3D technologies
Intraarticular controlled release
BY KEVIN GRØNNEMANN Published 06.08.19 at 07:37
A group of former Novozymes employees have founded their own biotech company, Hyamedix, to continue development of a medical technology based on hyaluronic acid. Novozymes scrapped the technology in 2015 but the new company has high aspirations.
https://medwatch.dk/secure/Top_picks_in_english/article11533448
Aarhus University News
BY METTE LOUISE OHANA 2019.08.08
3D printing can be big business for the university, thanks to Health researcher
A technique for printing soft parts using a 3D printer which can, among other things, replace transplanted tissue, has just been outsourced to the company Hyamedix. Assistant Professor Dang Quang Svend Le from Aarhus University and Aarhus University Hospital is the man behind the invention.
Read the article at Health’s website:
View video:
Please contact us directly with any questions, comments, or scheduling inquiries.
Copenhagen Bio Science Park, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark
Copyright © 2020 Hyamedix, ApS - All Rights Reserved.